Under the guidance to the end of December 2015, the state-run hair No. 7 ", Planning Commission" 70 ", part of the province of drug bidding in began to continue to unfold, policy fire is big, fierce market competition, enterprises to cope with busy, even to the moment of life and death!

But there are still many provinces not only not opening, hasn't even begun or slow progress, how to engage the provincial tender, enterprise how to deal with? The bid after the market how the Jedi counterattack? Supplementary drug use catalogue constantly emerging, how to deal with the large variety of?
At the same time, the state requires the reform of Medicare payment methods to cover all public hospitals in the region, and gradually cover all medical services. The establishment of Medicare payment standard in pharmaceutical companies pulling tension, which will directly link and price. But in the past by the service fees, the future is to explore the total control fees, according to the type of payment, according to the head pay (outpatient), according to the service unit, etc., Medicare payment system reform has been fully open.
Medical insurance cost control mechanism reform, the efficiency of medical service, modern health care system and the modern hospital system will soon form, which will be in future prices and the market formed from a key role to the, to the traditional "medicine" and "medicine" of the health insurance business model formation huge impact, pharmaceutical companies how to do?
Under China's current economic three superimposed effect, the fourth period of superposition is formed, the pharmaceutical industry environment of three superimposed also brought structural changes in the industry, industry has changeable, uncertain, release, coverage, inflection point, the watershed and other new features, face the future, policy is continued coverage? Industry enterprises are facing adverse environmental changes, as many as 18 of the.
Health care reform Planning Commission, the Ministry of social security, the Ministry of industry, development and Reform Commission, the food and drug administration, the Ministry of finance, the State Administration of Taxation, the Ministry of Commerce, etc., are in the introduction of relevant policies and documents, governance environment, promote reform. How to distinguish the current situation, to control the direction, do strategizing, winning thousands of miles?
During the twelfth five year plan, the four provincial medical reform pilot, the abolition of drug addition, medical service price increases, the implementation of drug procurement has become the main theme of the reform of public hospitals. In the relevant ministries brewing formulation, thirteen five planning will soon be launched in the background, the future of the health care reform will be how to walk? How in the pharmaceutical companies of the reform policy is complex and uncertain, to find their way out?
Strong demand for the vast number of pharmaceutical enterprises should, under the guidance of China Pharmaceutical Enterprise Management Association, scheduled for January 9, 2016 - 10 days in Beijing held the fifth session of the China pharmaceutical policy trend analysis report - New - health care reform, bidding policy, 45 planning and health care reform trend.
This report will invite people club department, the Ministry of industry and trade, health planning, relevant ministries and government officials attended the lecture; invite on tendering, health care, drug prices subject group members and industry associations responsible for people and other authoritative expert speech; invite of policy research and practical speakers. Reveal the new deal points, research to determine the trend of the new deal, analysis of the impact of the new deal perspective, to guide the support of enterprises to deal with.

At the same time, the state requires the reform of Medicare payment methods to cover all public hospitals in the region, and gradually cover all medical services. The establishment of Medicare payment standard in pharmaceutical companies pulling tension, which will directly link and price. But in the past by the service fees, the future is to explore the total control fees, according to the type of payment, according to the head pay (outpatient), according to the service unit, etc., Medicare payment system reform has been fully open.
Medical insurance cost control mechanism reform, the efficiency of medical service, modern health care system and the modern hospital system will soon form, which will be in future prices and the market formed from a key role to the, to the traditional "medicine" and "medicine" of the health insurance business model formation huge impact, pharmaceutical companies how to do?
Under China's current economic three superimposed effect, the fourth period of superposition is formed, the pharmaceutical industry environment of three superimposed also brought structural changes in the industry, industry has changeable, uncertain, release, coverage, inflection point, the watershed and other new features, face the future, policy is continued coverage? Industry enterprises are facing adverse environmental changes, as many as 18 of the.
Health care reform Planning Commission, the Ministry of social security, the Ministry of industry, development and Reform Commission, the food and drug administration, the Ministry of finance, the State Administration of Taxation, the Ministry of Commerce, etc., are in the introduction of relevant policies and documents, governance environment, promote reform. How to distinguish the current situation, to control the direction, do strategizing, winning thousands of miles?
During the twelfth five year plan, the four provincial medical reform pilot, the abolition of drug addition, medical service price increases, the implementation of drug procurement has become the main theme of the reform of public hospitals. In the relevant ministries brewing formulation, thirteen five planning will soon be launched in the background, the future of the health care reform will be how to walk? How in the pharmaceutical companies of the reform policy is complex and uncertain, to find their way out?
Strong demand for the vast number of pharmaceutical enterprises should, under the guidance of China Pharmaceutical Enterprise Management Association, scheduled for January 9, 2016 - 10 days in Beijing held the fifth session of the China pharmaceutical policy trend analysis report - New - health care reform, bidding policy, 45 planning and health care reform trend.
This report will invite people club department, the Ministry of industry and trade, health planning, relevant ministries and government officials attended the lecture; invite on tendering, health care, drug prices subject group members and industry associations responsible for people and other authoritative expert speech; invite of policy research and practical speakers. Reveal the new deal points, research to determine the trend of the new deal, analysis of the impact of the new deal perspective, to guide the support of enterprises to deal with.